BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16488015)

  • 21. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
    Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning.
    Berend S; Vrdoljak AL; Radić B; Kuca K
    Chem Biol Interact; 2008 Sep; 175(1-3):413-6. PubMed ID: 18547553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection by sustained release of physostigmine and procyclidine of soman poisoning in rats.
    Choi EK; Park D; Yon JM; Hur GH; Ha YC; Che JH; Kim J; Shin S; Jang JY; Hwang SY; Seong YH; Kim DJ; Kim JC; Kim YB
    Eur J Pharmacol; 2004 Nov; 505(1-3):83-91. PubMed ID: 15556140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-exposure therapy with human butyrylcholinesterase following percutaneous VX challenge in guinea pigs.
    Mumford H; E Price M; Lenz DE; Cerasoli DM
    Clin Toxicol (Phila); 2011 Apr; 49(4):287-97. PubMed ID: 21563904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of poisoning by soman.
    Leadbeater L; Inns RH; Rylands JM
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S225-31. PubMed ID: 4092890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidotes for nerve agent poisoning: should we differentiate children from adults?
    Baker MD
    Curr Opin Pediatr; 2007 Apr; 19(2):211-5. PubMed ID: 17496768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotinic mechanisms contribute to soman-induced symptoms and lethality.
    Hassel B
    Neurotoxicology; 2006 Jul; 27(4):501-7. PubMed ID: 16500708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Swine models in the design of more effective medical countermeasures against organophosphorus poisoning.
    Dorandeu F; Mikler JR; Thiermann H; Tenn C; Davidson C; Sawyer TW; Lallement G; Worek F
    Toxicology; 2007 Apr; 233(1-3):128-44. PubMed ID: 17092624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An in vitro comparative study on the reactivation of nerve agent-inhibited guinea pig and human acetylcholinesterases by oximes.
    Luo C; Tong M; Chilukuri N; Brecht K; Maxwell DM; Saxena A
    Biochemistry; 2007 Oct; 46(42):11771-9. PubMed ID: 17900152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of antidotes: problems and strategies.
    Szinicz L; Worek F; Thiermann H; Kehe K; Eckert S; Eyer P
    Toxicology; 2007 Apr; 233(1-3):23-30. PubMed ID: 16949190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and physiological effects of human butyrylcholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guinea-pig.
    Mumford H; Price ME; Cerasoli DM; Teschner W; Ehrlich H; Schwarz HP; Lenz DE
    Chem Biol Interact; 2010 Sep; 187(1-3):304-8. PubMed ID: 20176007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticonvulsants for nerve agent-induced seizures: The influence of the therapeutic dose of atropine.
    Shih TM; Rowland TC; McDonough JH
    J Pharmacol Exp Ther; 2007 Jan; 320(1):154-61. PubMed ID: 17015638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning.
    Balali-Mood M; Hefazi M
    Fundam Clin Pharmacol; 2005 Jun; 19(3):297-315. PubMed ID: 15910653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic prophylaxis against nerve agent poisoning.
    Layish I; Krivoy A; Rotman E; Finkelstein A; Tashma Z; Yehezkelli Y
    Isr Med Assoc J; 2005 Mar; 7(3):182-7. PubMed ID: 15792266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lessons to be learnt from organophosphorus pesticide poisoning for the treatment of nerve agent poisoning.
    Thiermann H; Szinicz L; Eyer P; Felgenhauer N; Zilker T; Worek F
    Toxicology; 2007 Apr; 233(1-3):145-54. PubMed ID: 17161895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stress adversely affects efficacy of physostigmine-scopolamine pretreatment against soman in guinea pigs.
    Philippens IH; Joosen MJ; Vanwersch RA
    Pharmacol Biochem Behav; 2005 Sep; 82(1):125-32. PubMed ID: 16126267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment efficacy in a soman-poisoned guinea pig model: added value of physostigmine?
    Joosen MJ; Smit AB; van Helden HP
    Arch Toxicol; 2011 Mar; 85(3):227-37. PubMed ID: 20842348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential role of bioscavenger in the medical management of nerve-agent poisoned casualties.
    Rice H; Mann TM; Armstrong SJ; Price ME; Green AC; Tattersall JEH
    Chem Biol Interact; 2016 Nov; 259(Pt B):175-181. PubMed ID: 27144491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effects of S+ ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guinea-pigs.
    Dorandeu F; Baille V; Mikler J; Testylier G; Lallement G; Sawyer T; Carpentier P
    Toxicology; 2007 May; 234(3):185-93. PubMed ID: 17408839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutamate receptor pathology is present in the hippocampus following repeated sub-lethal soman exposure in the absence of spatial memory deficits.
    Johnson EA; Daugherty KS; Gallagher SJ; Moran AV; DeFord SM
    Neurotoxicology; 2008 Jan; 29(1):73-80. PubMed ID: 17942156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.